about
Inflammation and cancer: till death tears them apart.Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.Prognostic value of tumour-associated macrophages in canine mammary tumours.High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.A role for T-lymphocytes in human breast cancer and in canine mammary tumorsA Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.Comparison of veterinary health services expectations and perceptions between oncologic pet owners, non-oncologic pet owners and veterinary staff using the SERVQUAL methodology.Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.Study of c-kit immunoexpression in canine cutaneous melanocytic tumors.Hematologic and blood chemistry values of healthy Cebus flavius kept in northeast of Brazil.Positive correlation of steroid hormones and EGF in canine mammary cancer.Role of steroid hormones and prolactin in canine mammary cancer.Biometric values, C-reactive protein, and proteinogram of healthy blonde capuchin (Sapajus flavius) kept in northeast of Brazil.Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours.Primary and secondary tumours occurring simultaneously in the brain of a dog.Immunohistochemical Labelling for Cyclo-oxygenase-2: Does the Positive Control Guarantee Standardized Results?Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.Mammary invasive micropapillary carcinoma in a male cat: Immunohistochemical description and clinical follow-up.Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.Curcumin and Rutin Down-regulate Cyclooxygenase-2 and Reduce Tumor-associated Inflammation in HPV16-Transgenic Mice.Comparative aspects of canine and human inflammatory breast cancer.Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages.High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival.Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours.Congenital hepatic fibrosis and polycystic kidney disease not linked to C >A mutation in exon 29 of PKD1 in a Persian cat.Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumoursConcurrent Expression of Cyclo-oxygenase-2 and Epidermal Growth Factor Receptor in Canine Malignant Mammary TumoursEGFR and microvessel density in canine malignant mammary tumoursEvaluation of Cyclooxygenase-2 Expression in Canine Mast Cell TumoursCOX-1 and COX-2 Expression in Canine Cutaneous, Oral and Ocular Melanocytic TumoursContribution of cyclo-oxygenase-2 to the angiogenic switch in canine inflammatory mammary carcinomasCOX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancerKaposi-Like Vascular Tumor of the Urinary Bladder in a Cow
P50
Q38485607-768B4932-7EE9-4401-9B65-DEC2445A183EQ38968185-C0D807DA-2915-4DC1-954F-9C302C49D194Q39186863-C52E2412-0621-4537-B7F7-F46687CEDB5FQ39624921-C43CD3C5-869D-4CB4-B91B-7D83168D5944Q40080923-E0EB2FF5-A3E4-4D5A-9E8F-150C7438C6FEQ41966647-6FED895D-6970-4E85-BDAD-1FB382C25823Q42344612-1D4E21BB-EA4C-433F-8A10-9F28B4DF4C1CQ42355786-E0E7810D-BE89-4405-B3F9-0260C3A9B290Q43104484-B2A3CE2B-88C6-451C-BEAB-06931E30CE02Q43691524-E7047637-5BE1-4861-8326-08AD2EC2384CQ44910326-808B0D1E-49B1-4ABF-AB73-134928A58D6AQ45901619-FE09E3C6-8294-44B1-B936-F9974BF8293AQ46017687-6D3BEE4F-C2D5-4607-9C96-8826CFC74A38Q46465071-3897AE74-4BB9-48D9-A0EB-67DD95A76D21Q46489506-8C3BE14D-BD0D-4B35-BBA1-E16AA46EB408Q46681697-A3EFD1E7-F0E5-4F5C-97C1-6F0004A26D65Q48412000-7A452DCD-B2CD-4083-9D29-82DEEC72E2B9Q49070852-844CF8D3-58FE-4DC4-AB51-11BCB76580CAQ51122714-46DBDC13-1887-4774-A096-385BD950881CQ51338743-1BC78E9D-D9C0-4053-B3CE-2068CD4D652DQ51590760-37170462-6871-41F6-8AA9-1154DC39C06DQ51601413-33259C79-92DD-4664-9C06-5191EF844AC3Q51737235-47C4D0DC-7E66-45D6-B638-BAB148C46DC5Q52662178-188F8C93-4232-4463-A1DA-10AFE0D81A62Q52715184-D734075F-65B8-4B8B-922B-E423AF8860E1Q52773381-7A6CCCD0-537C-4A79-B8EE-B408F57C3750Q52883009-D377C44D-A698-40CF-BAB5-938E25B31D43Q53104819-D189955C-F5A1-4DD5-850B-E81218841CE9Q53117077-B180F538-730F-42F1-BE59-D36C338D50BEQ53259449-5204FF71-CDD3-4E49-BDA0-683833E686D9Q53312576-C0673A52-0DFF-4ADC-8FC1-D369F16E8CE0Q53354125-74DB5AA5-A294-4676-89FC-FE5D67F22065Q59519793-4B68A2D9-5A3F-4C92-9BE6-A418BC7E87A5Q59519924-12A0D6D4-F890-45E5-B154-0D38AC0A2BD2Q59519946-DC52CB73-C42E-4A49-8EF5-128240F80B9EQ59519974-7E68F13F-C626-4030-A21E-FAD6F566CC97Q59520030-A4C8F24E-002A-41E4-A6BF-19376B92D462Q61765543-743D8446-14D2-4716-9043-E5EBCCB6E6C8Q61765572-A6D324C6-29FE-4812-9FC4-06EEA4CB4F58Q61765596-59A09BBD-4A6E-4FA4-91DD-61D6D1456556
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Felisbina L. Queiroga
@ast
Felisbina L. Queiroga
@en
Felisbina L. Queiroga
@es
Felisbina L. Queiroga
@nl
Felisbina L. Queiroga
@sl
type
label
Felisbina L. Queiroga
@ast
Felisbina L. Queiroga
@en
Felisbina L. Queiroga
@es
Felisbina L. Queiroga
@nl
Felisbina L. Queiroga
@sl
prefLabel
Felisbina L. Queiroga
@ast
Felisbina L. Queiroga
@en
Felisbina L. Queiroga
@es
Felisbina L. Queiroga
@nl
Felisbina L. Queiroga
@sl
P1053
L-5169-2013
P106
P1153
9332477900
P21
P31
P3829
P496
0000-0001-6130-8381